SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-22-000010
Filing Date
2022-06-15
Accepted
2022-06-15 15:30:16
Documents
43
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 vsbc_quarted10q.htm   iXBRL 10-Q 323484
2 ex31_1.htm EX-31.1 10927
3 ex31_2.htm EX-31.2 10785
4 ex32_1.htm EX-32.1 4122
5 ex32_2.htm EX-32.2 4044
  Complete submission text file 0001697884-22-000010.txt   1890807

Data Files

Seq Description Document Type Size
6 vsbc-20220430.xsd EX-101.SCH 13461
7 vsbc-20220430_cal.xml EX-101.CAL 19607
8 vsbc-20220430_def.xml EX-101.DEF 17000
9 vsbc-20220430_lab.xml EX-101.LAB 132393
10 vsbc-20220430_pre.xml EX-101.PRE 98801
37 EXTRACTED XBRL INSTANCE DOCUMENT vsbc_quarted10q_htm.xml XML 214127
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 221017647
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services